Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PROCEPT BioRobotics (PRCT) EBT (2020 - 2025)

Historic EBT for PROCEPT BioRobotics (PRCT) over the last 6 years, with Q3 2025 value amounting to -$21.4 million.

  • PROCEPT BioRobotics' EBT fell 208.35% to -$21.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$84.6 million, marking a year-over-year increase of 1546.96%. This contributed to the annual value of -$91.4 million for FY2024, which is 1367.74% up from last year.
  • As of Q3 2025, PROCEPT BioRobotics' EBT stood at -$21.4 million, which was down 208.35% from -$19.6 million recorded in Q2 2025.
  • In the past 5 years, PROCEPT BioRobotics' EBT registered a high of -$12.8 million during Q1 2021, and its lowest value of -$28.5 million during Q1 2023.
  • Moreover, its 5-year median value for EBT was -$21.4 million (2025), whereas its average is -$21.4 million.
  • Per our database at Business Quant, PROCEPT BioRobotics' EBT plummeted by 6574.92% in 2023 and then soared by 3144.27% in 2024.
  • Over the past 5 years, PROCEPT BioRobotics' EBT (Quarter) stood at -$18.3 million in 2021, then plummeted by 35.79% to -$24.9 million in 2022, then fell by 10.4% to -$27.5 million in 2023, then surged by 31.44% to -$18.9 million in 2024, then decreased by 13.55% to -$21.4 million in 2025.
  • Its EBT stands at -$21.4 million for Q3 2025, versus -$19.6 million for Q2 2025 and -$24.7 million for Q1 2025.